Cargando…
Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial
INTRODUCTION: Sodium glucose co-transporter 2 (SGLT2) inhibitors are widely used in the management of type 2 diabetes mellitus; they prevent cardiovascular events and reduce fat mass. However, little is known about the effects of SGLT2 inhibitors on type 1 diabetes mellitus as an adjuvant to insulin...
Autores principales: | Baba, Yusuke, Ishibashi, Ryoichi, Takasaki, Atsushi, Ito, Chiho, Watanabe, Atsuko, Tokita, Megumi, Meguro, Miwako, Harama, Tomomi, Hirayama, Kiichi, Yamamoto, Tetsuya, Nakamura, Susumu, Koshizaka, Masaya, Maezawa, Yoshiro, Uchida, Daigaku, Okajima, Fumitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099976/ https://www.ncbi.nlm.nih.gov/pubmed/33738773 http://dx.doi.org/10.1007/s13300-021-01047-5 |
Ejemplares similares
-
Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan
por: Ishibashi, Ryoichi, et al.
Publicado: (2020) -
Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
por: Ishibashi, Ryoichi, et al.
Publicado: (2023) -
Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020) -
Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017) -
Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)